Point of View
Results of the REVEAL study. Why should we not welcome a new lipid-lowering agent?
Resultados del estudio REVEAL. ¿Por qué no debemos dar la bienvenida a un nuevo agente hipolipemiante?
Luis Masana
Unitat de Medicina Vascular i Metabolisme, Hospital Universitari Sant Joan, Universitat Rovira I Virgili, IISPV, CIBERDEM, Reus, Tarragona, Spain
Read
289
Timeswas read the article
101
Total PDF
188
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 May | 3 | 1 | 4 |
| 2024 April | 7 | 8 | 15 |
| 2024 March | 10 | 2 | 12 |
| 2024 February | 11 | 6 | 17 |
| 2024 January | 9 | 1 | 10 |
| 2023 December | 6 | 9 | 15 |
| 2023 November | 8 | 10 | 18 |
| 2023 October | 12 | 5 | 17 |
| 2023 September | 9 | 2 | 11 |
| 2023 August | 6 | 1 | 7 |
| 2023 July | 2 | 1 | 3 |
| 2023 June | 4 | 5 | 9 |
| 2023 May | 8 | 1 | 9 |
| 2023 April | 1 | 0 | 1 |
| 2023 March | 4 | 3 | 7 |
| 2023 February | 4 | 0 | 4 |
| 2023 January | 8 | 1 | 9 |
| 2022 December | 10 | 2 | 12 |
| 2022 November | 5 | 6 | 11 |
| 2022 October | 6 | 5 | 11 |
| 2022 September | 4 | 4 | 8 |
| 2022 August | 9 | 6 | 15 |
| 2022 July | 7 | 4 | 11 |
| 2022 June | 8 | 3 | 11 |
| 2022 May | 6 | 3 | 9 |
| 2022 April | 8 | 5 | 13 |
| 2022 March | 5 | 5 | 10 |
| 2022 February | 8 | 2 | 10 |
Show all